<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02316704</url>
  </required_header>
  <id_info>
    <org_study_id>G7_RSA_v1.02</org_study_id>
    <nct_id>NCT02316704</nct_id>
  </id_info>
  <brief_title>Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty</brief_title>
  <official_title>Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty: A Single-Blinded Randomized Controlled Trial Evaluating Implant Migration, Acetabular Liner Wear, and Patient Reported Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this project is to investigate, using RSA, acetabular implant
      migration of the OsseoTi™ G7 acetabular cup in comparison to conventional PPS coated G7
      acetabular cup, and compare liner wear of thinnest available E1™ liner, allowing for the
      largest possible femoral head (36mm-44mm) to E1™ liner holding a 32mm femoral head in the G7
      acetabular system with endpoint assessment being performed at the 2 year follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RSA migration in 3 dimentions of the acetabular components as measured by Radiostereometric analysis, RSA.</measure>
    <time_frame>2 year</time_frame>
    <description>Radiostereometric analysis, RSA, is an accurate technique for measuring small relative motions from sequential sets of radiographs over time and has been used to measure polyethylene wear and implant migration. Measurements are performed in microns.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">98</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>OsseoTi™ G7 large</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OsseoTi™ G7 acetabular cup and an E1™ liner holding largest possible femoral head (36mm-44mm)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OsseoTi™ G7 32</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OsseoTi™ G7 acetabular cup and an E1™ insert holding a 32mm femoral head</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional PPS coated G7 large</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional PPS coated G7 acetabular cup and an E1™ insert holding largest possible femoral head (36mm-44mm)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional PPS coated G7 32</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional PPS coated G7 acetabular cup and an E1™ insert holding a 32mm femoral head</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THA with G7 PPS coted acetabular component</intervention_name>
    <arm_group_label>OsseoTi™ G7 large</arm_group_label>
    <arm_group_label>OsseoTi™ G7 32</arm_group_label>
    <arm_group_label>conventional PPS coated G7 large</arm_group_label>
    <arm_group_label>conventional PPS coated G7 32</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THA with G7 OsseoTi coted acetabular component</intervention_name>
    <arm_group_label>OsseoTi™ G7 large</arm_group_label>
    <arm_group_label>OsseoTi™ G7 32</arm_group_label>
    <arm_group_label>conventional PPS coated G7 large</arm_group_label>
    <arm_group_label>conventional PPS coated G7 32</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Participants with primary hip osteoarthritis set to receive a primary unilateral
             uncemented total hip arthroplasty.

               -  Participants must be 18-75 years of age.

               -  Participants must be able to speak and understand Danish (or depending on country
                  where patient is enrolled).

               -  Participants must be able to give informed consent and be cognitively intact.

               -  Participants must be expected to be able to complete all postoperative controls.

               -  Participants must not have severe comorbidities, ASA-score ≤ 3.

        Exclusion Criteria:

          -  Terminal illness.

          -  Rheumatoid arthritis.

          -  Previous fracture of the hip.

          -  Osteonecrosis of the hip.

          -  Previous infection of the hip.

          -  Severe bony deformity warranting the use of non-standard implants.

          -  Metastasis in the periarticular bone or proximal femur.

          -  Female patients that are pregnant or planning pregnancy during follow-up period

          -  If bone stock or femoral canal type, assessed on preoperative x-ray, warrants the use
             of cemented fixation.

          -  Documented osteoporosis with patient in active medical treatment.

          -  Comorbidity with altered pain perception (e.g. DM with neuropathy).

          -  Participants that develop deep infection in the follow-up period are excluded from the
             project.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dept. of Orthopaedic Surgery, Copenhagen University Hospital Hvidovre</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital, Department of Orthopedics,</name>
      <address>
        <city>Gothenburg</city>
        <zip>SW-431 80</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2014</study_first_submitted>
  <study_first_submitted_qc>December 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2014</study_first_posted>
  <last_update_submitted>February 24, 2017</last_update_submitted>
  <last_update_submitted_qc>February 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Kirill Gromov</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

